Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness

Triple-negative breast cancer (TNBC) is cancer that tested as negative for estrogen receptors (ER), progesterone receptors (PR), and excess human epidermal growth factor receptor 2 (HER2) protein which accounts for 15%–20% of all breast cancer cases. TNBC is considered to be a poorer prognosis than...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Kha-Liang, Kuo, Yung-Che, Ho, Yuan-Soon, Huang, Yen-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769912/
https://www.ncbi.nlm.nih.gov/pubmed/31505803
http://dx.doi.org/10.3390/cancers11091334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769912/
https://www.ncbi.nlm.nih.gov/pubmed/31505803
http://dx.doi.org/10.3390/cancers11091334

Ejemplares similares